NasdaqHealth CarePharmaceutical PreparationsSOUTH SAN FRANCISCO, CATheme: GLP-1 and obesity

Structure Therapeutics Inc. GPCR

Ask your AI

ADR: the number of shares per ADR isn’t known yetCIK 1888886

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

104

34 added · 36 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Structure Therapeutics Inc.'s latest quarterly report, compared with the one before.

Filed Nov 9, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Structure Therapeutics Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

22.54M shares

104 funds report GPCR. Values checked against market prices.

Q3 2026. 13 new, 34 added to, 36 trimmed, 104 exited since Q2 2026.

Top 13F holders
#
1	FMR LLC 13F ↗	9.35M	$292.5M	+19.8%
2	Morgan Stanley 13F ↗	2.82M	$88.1M	+0.4%
3	Principal Financial Group Inc 13F ↗	1.26M	$39.6M	-27.8%
4	Siren, LLC 13F ↗	872,967	$27.3M	unchanged
5	Aberdeen Group plc 13F ↗	858,784	$26.9M	+34.2%
6	Capitolis Liquid Global Markets LLC 13F ↗	835,000	$26.1M	-19.8%
7	Pacific Heights Asset Management LLC 13F ↗	800,000	$25.0M	unchanged
8	BlackRock, Inc. 13F ↗	705,946	$22.1M	+38.1%
9	JPMorgan Chase & Co 13F ↗	546,189	$17.9M	+13609.6%
10	UBS Group AG 13F ↗	332,122	$10.4M	-12.4%

Download CSV Every fund that holds GPCR, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Structure Therapeutics Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Structure Therapeutics Inc. and its lobbying firms report each quarter.

Loading…

Part of themes

Themes on 13F.ai that include GPCR, and why.

GLP-1 and obesityDevelopersDeveloping oral obesity drug candidates (Structure Therapeutics)

A theme lists companies with something in common under a published rule. It is not a recommendation.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2023	38	—	16.01M	$375.9M
Q2 2023	48	+10	17.65M	$699.3M
Q3 2023	84	+36	32.79M	$1.6B
Q4 2023	121	+37	42.88M	$1.7B
Q1 2024	119	-2	44.25M	$1.9B
Q2 2024	166	+47	60.39M	$2.4B
Q3 2024	160	-6	61.59M	$2.7B
Q4 2024	164	+4	60.66M	$1.6B
Q1 2025	153	-11	55.96M	$981.0M
Q2 2025	173	+20	54.67M	$1.1B
Q3 2025	158	-15	56.77M	$1.6B
Q4 2025	198	+40	65.78M	$4.6B
Q1 2026	197	-1	66.96M	$3.2B
Q2 2026	193	-4	67.60M	$3.6B
Q3 2026	104	-89	22.54M	$699.1M

Each point is a quarter-end, from Q1 2023 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (86366E106). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2023) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes6 in 12 mo 8-K events2 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 2 in 12 mo Executive pay3 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record IPO history3 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Structure Therapeutics Inc.
Address: 601 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 457-1978
Fiscal year ends: Dec 31
Filer category: Large accelerated filer
Incorporated in: Cayman Islands
Listed as: GPCR (Nasdaq)
Former names: ShouTi Inc. (until 2022)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$20.00+$0.16 (+0.81%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $19.08 · High $22.88Nov 13, 2026

Aug 13, 2026Low $19.08 · High $54.70Nov 13, 2026

Nov 13, 2025Low $19.08 · High $93.79Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.